Tempest Therapeutics Filing Becomes Effective
Ticker: TPST · Form: EFFECT · Filed: 2026-04-06T00:15:20-04:00
Sentiment: neutral
Topics: filing-effectiveness, sec-filing, procedural
TL;DR
Tempest Therapeutics filing is now effective as of 4/3/2026. Go time.
AI Summary
Tempest Therapeutics, Inc. filed an EFFECT form with the SEC on April 6, 2026, indicating the effectiveness of a filing related to their securities. The effectiveness date is noted as April 3, 2026. The company's principal executive offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
Why It Matters
This filing signifies that a previous registration statement or filing with the SEC has been approved and is now in effect, allowing for certain corporate actions or offerings to proceed.
Risk Assessment
Risk Level: low — An EFFECT filing itself is a procedural notification and does not inherently carry significant financial risk.
Key Numbers
- 0001544227 — CIK (Tempest Therapeutics' unique identifier with the SEC.)
- 333-294740 — File Number (The specific SEC file number associated with this filing.)
Key Players & Entities
- Tempest Therapeutics, Inc. (company) — Filer
- 2000 Sierra Point Parkway Suite 400 Brisbane CA 94005 (location) — Mailing and Business Address
- 415-798-8589 (phone_number) — Contact Number
- 0001544227 (cik) — Company Identification Number
- 333-294740 (file_number) — SEC File Number
- 2026-04-06 (date) — Acceptance Date
- 2026-04-03 (date) — Effectiveness Date
FAQ
What type of filing is an 'EFFECT' form?
An 'EFFECT' form is a Notice of Effectiveness, indicating that a previously filed registration statement or other document with the SEC has been declared effective.
When was this filing accepted by the SEC?
This filing was accepted by the SEC on April 6, 2026.
What is the effectiveness date mentioned in the filing?
The effectiveness date mentioned is April 3, 2026.
Where are Tempest Therapeutics, Inc.'s principal offices located?
Tempest Therapeutics, Inc.'s principal offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.
What is the SIC code for Tempest Therapeutics, Inc.?
The SIC code for Tempest Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 9999999995-26-001088 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001088 Accepted 2026-04-06 00:15:20 Documents 1 Effectiveness Date 2026-04-03 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 596 Complete submission text file 9999999995-26-001088.txt 1968 Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589 Tempest Therapeutics, Inc. (Filer) CIK : 0001544227 (see all company filings) EIN. : 451472564 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294740 | Film No.: 26839471 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)